The National Bleeding Disorders Foundation (NBDF) is alerting the community to updated information from Takeda Pharmaceutical Company regarding the discontinuation timelines for HEMOFIL® M and RECOMBINATE®, two therapies used to treat hemophilia A,…
Dr. Deeksha Katoch is a third-year pediatric hematology-oncology fellow at Yale University School of Medicine with a clinical and research focus in benign hematology and inherited bleeding disorders. She will be joining the faculty of the Yale…
Dr. Zhao was originally born in Jinan, China and moved to the United States at an early age of 4. He grew up in Houston (TX), Richmond (VA), and Atlanta (GA). Dr. Zhao went to college at Emory University and majored in Chemistry (BS) before going to…
Federal:Strong Support for FY27 Funding for Federal Bleeding Disorders Programs During Washington Days, advocates asked Congressional offices to support funding for federal bleeding disorders programs for…
#bdbody {
width: 80%;
margin: 0 auto;
padding: 1rem;
}
/* Mobile and tablet: 100% width */
@media (max-width: 991px) {
#bdbody {
width: 100%;
padding: 1rem; /* optional padding for small screens…
The National Bleeding Disorders Foundation, a leading U.S. organization dedicated to improving care for people with bleeding disorders, has announced its 2025 NBDF-Takeda Clinical Fellowship Awardees: Deeksha Katoch, MBBS, and Peter Zhao, MD.…
Star Therapeutics is investigating a once-monthly subcutaneous prophylactic treatment for VWD called VGA039. If you or someone in your family has any type of VWD, please join us for an engaging session as Dr. Benjamin Kim, senior vice president of…
Visit the chapter website using the link below for more details and timing of the Bleeding Disorders Summer Camp - SC event.